Dexamethasone induced hyperglycaemia and adverse outcomes – are we there yet?
Dhatariya K.
Medical Hypothesis 2022;164:110879
Medical Hypothesis 2022;164:110879
Glycated haemoglobin (HbA1c) and the risk of postoperative complications in people with and without diabetes: a prospective population-based study in UK Biobank.
Lam S, Kumar B, Loke Y, Orme S, Dhatariya K.
Anaesthesia 2022;77(6):659-667
Anaesthesia 2022;77(6):659-667
Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes – an updated guideline from the Joint British Diabetes Society for Inpatient Care.
Dashora U, Levy N, Dhatariya K, Willer N, Castro E, Murphy HR, group TJBDSIP.
Diabetic Medicine 2022;39:e14744
Diabetic Medicine 2022;39:e14744
A guideline for the outpatient management of glycaemic control in people with cancer
Joharatnam-Hogan N, Chambers P, Dhatariya K, Board R, on behalf of the Joint British Diabetes Society for Inpatient Care (JBDS) and UK Chemotherapy Board (UKCB).
Diabetic Medicine 2022;39(1):e14636
Diabetic Medicine 2022;39(1):e14636
The association between glycemic variability and the development of retinopathy in people with diabetes: A retrospective case-control study.
Dhatariya K, Humberstone A, Hasnat A, Wright R, Lujan M, Nunney I
Diabetes Therapy 2021;12(10):2755-2766
Diabetes Therapy 2021;12(10):2755-2766
Effects of the Norfolk diabetes prevention lifestyle intervention (NDPS) on glycaemic control in screen-detected Type 2 diabetes: a randomised controlled trial.
Sampson M, Clark A, Bachmann M, Garner N, Irvine L, Howe A, Greaves C, Auckland S, Smith J, Turner J, Rea D, Rayman G, Dhatariya K, John WG, Barton G, Usher R, Ferns C, Pascale M, on behalf of the NDPS group.
BMC Medicine 2021;19(1):183
BMC Medicine 2021;19(1):183
Surveillance of diabetes with inpatients on glucocorticoids – are the JBDS audit standards being met?
Limbachia V, Dhatariya K.
Practical Diabetes 2021;38(2):9-12
Practical Diabetes 2021;38(2):9-12
Lifestyle intervention with or without lay volunteers to prevent type 2 diabetes in people with impaired fasting glucose and/or nondiabetic hyperglycemia: A randomized clinical trial.
Sampson M, Bachmann M, Garner N, Irvine L, Howe A, Auckland S, Greaves C, Smith J, Turner J, Wallace T, Rae D, Rayman G, Dhatariya K, Goldson A, John G, Clark A, Barton G, Usher R, Ferns C, Pascale M.
JAMA Internal Medicine 2021;181(2):168-178
Risk prediction of the missing millions: Identifying individuals at high risk of diabetes and diabetes-related complications.
Evans M, Morgan AR, Patel D, Dhatariya K, Greenwood S, Newland-Jones P, Hicks D, Yousef Z, Moore J, Kelly B, Davies S, Dashora U.
Diabetes Therapy 2021;12(1):87-105
Diabetes Therapy 2021;12(1):87-105
Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes
Rayman G, Lumb A, Kennon B, Cottrell D, Nagi D, Page E, Voigt D, Courtney H, Atkins H, Platts J, Higgins K, Dhatariya K, Patel M, Narendran P, Kar P, Newland-Jones P, Stewart R, Burr O, Thomas S.
Diabetic Medicine 2021;38(1):e14378
Diabetic Medicine 2021;38(1):e14378
A Joint British Diabetes Societies for Inpatient Care (JBDS-IP) clinical guideline on inpatient care of the frail older adult with diabetes: Executive summary
Sinclair AJ, Dashora U, George S, Dhatariya K.
Diabetic Medicine 2020;37(12):1981-1991
Diabetic Medicine 2020;37(12):1981-1991
The relationship between glycosylated haemoglobin levels and the risk of Giant Cell Arteritis – A case-control study.
Mukhtyar C, Myers H, Jones, C, Dhatariya, K.
Rheumatology Advances in Practice 2020;4(2):rkaa018
Rheumatology Advances in Practice 2020;4(2):rkaa018